- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07497334
Uma Abordagem Multi-Modal Inovadora para Promover Resultados Funcionais em Idosos com Fragilidade Cognitiva (TMS MRI TBS)
Uma Abordagem Multimodal Inovadora para Promover Resultados Funcionais em Idosos com Fragilidade Cognitiva
The goal of this clinical trial is to explore the effects of intermittent theta burst stimulation (iTBS) primed with theta burst stimulation (cTBS), on top of aerobic exercise, on cognitive function, mobility, and brain activity in older adults with cognitive frailty. Understanding these effects will help us develop intervention models that benefit cognitively frail older adults. The main questions it aims to answer are:
- Does the combination of iTBS primed with cTBS and aerobic exercise lead to greater improvements in cognition and mobility in older adults with cognitive frailty compared to non-priming iTBS and sham stimulation?
- What are the neural mechanisms responsible for the improvements in cognition and mobility associated with the combination of iTBS primed with cTBS and aerobic exercise in older adults with cognitive frailty?
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Objectives: To compare the effects of intermittent theta burst stimulation (iTBS) primed with continuous theta burst stimulation (cTBS), nonpriming iTBS, and sham stimulation on top of aerobic exercise in terms of improving cognitive function, mobility, brain structure, and brain function in older adults with cognitive frailty.
Hypothesis to be tested: We hypothesize that iTBS primed with cTBS can maximize the induction of therapeutically beneficial metaplasticity, and that this will be reflected in improved brain structure and brain function, thereby enabling superior cognitive function and mobility improvement in older adults with cognitive frailty.
Design and subjects: A randomized controlled trial involving 60 older adults with cognitive frailty.
Study instruments: Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI).
Interventions: Participants will be randomly allocated to receive a 39-session intervention with different TBS protocols (i.e., cTBS+iTBS, sham cTBS+iTBS, and sham cTBS+sham iTBS), delivered 3 times per week for 3 months. All participants will receive 60 minutes of aerobic exercise after each stimulation session for 6 months.
Main outcome measures: comprehensive neuropsychological battery covering major executive function (i.e., selective attention/response inhibition, psychomotor speed, set shifting), working memory, and verbal fluency; (2) mobility function evaluated via SPPB, Timed-Up-and-GO (TUG) test, functional gait analysis (i.e., gait speed, gait variability).
Secondary outcomes: underlying neural mechanisms of intervention-induced benefits will be assessed via functional and structural magnetic resonance imaging.
Data analysis: Analysis of variance (ANOVA)
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: JINGYI WU, MSc
- Número de telefone: +85260730847
- E-mail: 24144838r@connect.polyu.hk
Locais de estudo
-
-
-
Hong Kong, Hong Kong
- Recrutamento
- The Hong Kong Polytechnic University, Department of Rehabilitation Sciences
-
Contato:
- Chun Liang HSU, PhD
- Número de telefone: 852-27666755
- E-mail: chun-liang.hsu@polyu.edu.hk
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- be between 60 and 90 years old;
- scored < 9/12 on the Short Physical Performance Battery;
- scored >18/30 on the Montreal Cognitive Assessment;
- scored >9/42 on the Pictorial Fit-Frail Scale;
- lived in the community;
- be able to ambulate up to four meters with or without assistive devices;
- be able to provide written informed consent on their own behalf;
- can understand verbal and written Cantonese and/or English.
Exclusion Criteria:
- have magnetic resonance imaging contraindications;
- have aerobic exercise contraindications;
- have transcranial magnetic stimulation contraindications;
- be diagnosed with neurodegenerative conditions (i.e., dementia, Parkinson's, Alzheimer's disease, Amyotrophic lateral sclerosis, and stroke);
- live in a nursing home or other care facilities/institutions;
- bed taking fixed dose of medication or had been taking medications known to potentially affect cognitive and physical function (e.g., psychotropic medications), as identified through a review of their medication lists recorded in the health software. Medications were categorized by properties (e.g., antipsychotics, antidepressants, etc.) to inform eligibility decisions.
- have a history indicative of carotid sinus sensitivity (i.e., falls due to loss of consciousness);
- cancer and undergo radiation therapy.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: cTBS+iTBS, in addition to aerobic exercise
Participants will receive 600-pulse continuous theta burst stimulation (cTBS) at the intensity of 80% resting motor threshold (RMT) as the priming, followed by 600-pulse intermittent theta burst stimulation (iTBS) at the intensity of 80% RMT (i.e., priming iTBS). The stimulation will be delivered 3 sessions per week, lasting for 3 months. Participants will receive a 60-minute aerobic exercise after each stimulation session, lasting for 6 months |
Theta burst stimulation (TBS) will be administered using a figure-of-eight shaped cooling coil (Cool-B65 A/P), which generates auditory "clicks" for sham stimulation that are similar to those produced by active repetitive transcranial magnetic stimulation (rTMS). The placement of the coil will be guided by a navigation system (LOCALITE® TMS Navigator, Germany) using each participant's baseline T1-weighted Magnetic Resonance Imaging (MRI) scans. TBS is a powerful form of rTMS. Standard 600-pulse intermittent theta burst stimulation (iTBS) can enhance corticomotor excitability, whereas standard 600-pulse continuous theta burst stimulation (cTBS) can suppress it. The aerobic exercise sessions will include a 10-minute warm-up, followed by 40 minutes of brisk walking and/or stationary exercises without weights, and will conclude with a 10-minute cooldown. The intensity of the aerobic exercise will be monitored using heart rate, starting at 40% of the age-specific heart rate reserve (HRR), which is calculated using the formula: 207 - (0.7 x age). Over the initial 12 weeks, the intensity will be gradually increased until the HRR reaches 65%, and this level will be maintained until the end of the trial. |
|
Comparador Ativo: Sham cTBS + iTBS, in addition to aerobic exercise
Participants will receive sham 600-pulse cTBS at the intensity of 80% RMT as the priming, followed by 600-pulse iTBS at the intensity of 80% RMT (i.e., priming iTBS). The stimulation will be delivered 3 sessions per week, lasting for 3 months. Participants will receive a 60-minute aerobic exercise after each stimulation session, lasting for 6 months |
Theta burst stimulation (TBS) will be administered using a figure-of-eight shaped cooling coil (Cool-B65 A/P), which generates auditory "clicks" for sham stimulation that are similar to those produced by active repetitive transcranial magnetic stimulation (rTMS). The placement of the coil will be guided by a navigation system (LOCALITE® TMS Navigator, Germany) using each participant's baseline T1-weighted Magnetic Resonance Imaging (MRI) scans. TBS is a powerful form of rTMS. Standard 600-pulse intermittent theta burst stimulation (iTBS) can enhance corticomotor excitability, whereas standard 600-pulse continuous theta burst stimulation (cTBS) can suppress it. The aerobic exercise sessions will include a 10-minute warm-up, followed by 40 minutes of brisk walking and/or stationary exercises without weights, and will conclude with a 10-minute cooldown. The intensity of the aerobic exercise will be monitored using heart rate, starting at 40% of the age-specific heart rate reserve (HRR), which is calculated using the formula: 207 - (0.7 x age). Over the initial 12 weeks, the intensity will be gradually increased until the HRR reaches 65%, and this level will be maintained until the end of the trial. |
|
Comparador Falso: Sham cTBS + sham iTBS, in addition to aerobic exercise
Participants will receive sham 600-pulse cTBS at the intensity of 80% RMT as the priming, followed by sham 600-pulse iTBS at the intensity of 80% RMT (i.e., priming iTBS). The stimulation will be delivered 3 sessions per week, lasting for 3 months. Participants will receive a 60-minute aerobic exercise after each stimulation session, lasting for 6 months |
Theta burst stimulation (TBS) will be administered using a figure-of-eight shaped cooling coil (Cool-B65 A/P), which generates auditory "clicks" for sham stimulation that are similar to those produced by active repetitive transcranial magnetic stimulation (rTMS). The placement of the coil will be guided by a navigation system (LOCALITE® TMS Navigator, Germany) using each participant's baseline T1-weighted Magnetic Resonance Imaging (MRI) scans. TBS is a powerful form of rTMS. Standard 600-pulse intermittent theta burst stimulation (iTBS) can enhance corticomotor excitability, whereas standard 600-pulse continuous theta burst stimulation (cTBS) can suppress it. The aerobic exercise sessions will include a 10-minute warm-up, followed by 40 minutes of brisk walking and/or stationary exercises without weights, and will conclude with a 10-minute cooldown. The intensity of the aerobic exercise will be monitored using heart rate, starting at 40% of the age-specific heart rate reserve (HRR), which is calculated using the formula: 207 - (0.7 x age). Over the initial 12 weeks, the intensity will be gradually increased until the HRR reaches 65%, and this level will be maintained until the end of the trial. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Montreal Cognitive Assessment
Prazo: Baseline, 3 months, and 6 months
|
General cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA). The total MoCA score ranges from 0 to 30, with higher scores indicating better cognitive performance |
Baseline, 3 months, and 6 months
|
|
Short Physical Performance Battery
Prazo: Baseline, 3 months, and 6 months
|
Mobility will be assessed using the Short Physical Performance Battery (SPPB). The SPPB evaluates balance, gait speed, and chair stand performance, with total scores ranging from 0 to 12. Higher scores indicate better mobility |
Baseline, 3 months, and 6 months
|
|
Pictorial Fit-Frail Scale
Prazo: Baseline, 3 months, and 6 months
|
Frailty in older adults will be assessed using the Pictorial Fit-Frail Scale (PFFS). The PFFS evaluates 14 health domains, with total scores ranging from 0 to 43. Higher scores indicate a greater severity of frailty. |
Baseline, 3 months, and 6 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Six Minutes Walking Test
Prazo: Baseline, 3 months, and 6 months
|
The Six-Minute Walk Test (6MWT) is a practical, self-paced clinical test that measures the total distance an individual can walk on a flat, hard surface in six minutes. A longer distance walked reflects a higher level of functional mobility. |
Baseline, 3 months, and 6 months
|
|
Timed-Up-and-Go Test
Prazo: Baseline, 3 months, and 6 months
|
The Timed Up and Go (TUG) test is a standardized assessment used to evaluate mobility and gait. A longer completion time reflects poorer physical mobility. |
Baseline, 3 months, and 6 months
|
|
Task Switch Test
Prazo: Baseline, 3 months, and 6 months
|
The Task Switching Test is a standardized assessment used to evaluate executive function. A higher accuracy rate and a shorter reaction time reflect superior executive performance |
Baseline, 3 months, and 6 months
|
|
Digit Span Test
Prazo: Baseline, 3 months, and 6 months
|
The Digit Span Test is a standardized neuropsychological assessment used to evaluate attention and working memory. The test comprises two components: Digits Forward and Digits Backward. A higher cumulative score reflects better overall performance. Additionally, a smaller discrepancy score (calculated as the forward span minus the backward span) represents superior cognitive manipulation and updating ability. |
Baseline, 3 months, and 6 months
|
|
Digit Symbol Substitution Test
Prazo: Baseline, 3 months, and 6 months
|
The Digit Symbol Substitution Test (DSST) is a standardized neuropsychological instrument used to evaluate cognitive processing speed and executive function. The total score is determined by the number of correctly completed items within a specified time limit, with higher scores reflecting superior cognitive performance. |
Baseline, 3 months, and 6 months
|
|
Stroop Test
Prazo: Baseline, 3 months, and 6 months
|
The Stroop Test is a standardized neuropsychological assessment used to evaluate executive function, particularly inhibitory control. The completion time for each condition is recorded as the score, with shorter completion times reflecting superior executive performance. |
Baseline, 3 months, and 6 months
|
|
Trail Making Test
Prazo: Baseline, 3 months, and 6 months
|
The Trail Making Test will comprise Part A and Part B. In Part A, participants are instructed to connect numbers in sequential order (e.g., drawing a line from 1 to 2, 2 to 3, 3 to 4, etc.) while being timed. In Part B, participants are instructed to connect, in order, 25 encircled numbers and letters alternately (e.g., 1-A-2-B-3-C) while being timed. A longer time represents worse executive function. |
Baseline, 3 months, and 6 months
|
|
30-second sit to stand
Prazo: Baseline, 3 months, and 6 months
|
Functional mobility and lower-limb functional strength will be measured via the 30-Second Chair Stand Test (30CST). Participants stand up and sit down as rapidly and safely as possible for 30 seconds, where a higher repetition score indicates greater functional mobility. |
Baseline, 3 months, and 6 months
|
|
cortical and subcortical volume
Prazo: Baseline, 3 months, and 6 months
|
Cortical and subcortical volume will be examined in all participants using MRI. Participants will undergo structural MRI on the 3T Siemens scanner at the University Research Facility in Behavioral and Systems Neuroscience. Participants will complete T1 and T2 high resolution anatomical scans. |
Baseline, 3 months, and 6 months
|
|
Resting State-Functional Connectivity-Functional MRI
Prazo: Baseline, 3 months, and 6 months
|
Participants will be instructed to rest with eyes open for approximately 12 minutes. This will allow the investigators to examine activation in the resting state network. |
Baseline, 3 months, and 6 months
|
|
Physical Activity Scale for the Elderly
Prazo: Baseline, 3 months, and 6 months
|
Physical activity will be assessed by Physical Activity Scale for the Elderly (PASE), where a higher score indicates a higher level of physical activity. |
Baseline, 3 months, and 6 months
|
|
Geriatric Depression Scale
Prazo: Baseline, 3 months, and 6 months
|
Depression will be measured by Geriatric Depression Scale (GDS), where a higher score indicates a higher level of depressive symptoms |
Baseline, 3 months, and 6 months
|
|
Fatigue Severity Scale
Prazo: Baseline, 3 months, and 6 months
|
Physical fatigue will be measured by Fatigue Severity Scale (FSS), where a higher score indicates more severe fatigue |
Baseline, 3 months, and 6 months
|
|
Functional Comorbidity Index
Prazo: Baseline, 3 months, and 6 months
|
Total number of comorbid conditions will be assessed through the Functional Comorbidity Index (FCI), where a higher score indicates a greater comorbidity burden. |
Baseline, 3 months, and 6 months
|
|
Functional Activities Questionnaire
Prazo: Baseline, 3 months, and 6 months
|
The difficulties in activities of daily living will be assessed using the Functional Activities Questionnaire (FAQ), with higher scores reflecting severe difficulty in performing daily tasks. |
Baseline, 3 months, and 6 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Chun Liang HSU, PhD, The Hong Kong Polytechnic University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- HSEARS20240614001
- P0048639 (Número de outro subsídio/financiamento: The Hong Kong Polytechnic University)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .